Impact of comorbidities and co-medication on disease onset and progression in a large German ALS patient group-Reference-Cited by-同舟云学术

Impact of comorbidities and co-medication on disease onset and progression in a large German ALS patient group

Published:2020-04-07 Issue:7 Volume:267 Page:2130-2141
ISSN:0340-5354
Container-title:Journal of Neurology
language:en
Short-container-title:J Neurol

Author:

Diekmann Kristin,Kuzma-Kozakiewicz Magdalena,Piotrkiewicz Maria,Gromicho Marta,Grosskreutz Julian,Andersen Peter M.,de Carvalho Mamede,Uysal Hilmi,Osmanovic Alma,Schreiber-Katz Olivia,Petri Susanne,Körner Sonja

Funder

European Union

Publisher

Springer Science and Business Media LLC

Subject

Clinical Neurology,Neurology

Link

http://link.springer.com/content/pdf/10.1007/s00415-020-09799-z.pdf

Reference52 articles.

1. Silani V, Ludolph A, Fornai F (2017) The emerging picture of ALS: A multisystem, not only a “motor neuron disease”. Arch Ital Biol 155:99–109

2. Gallo V, Wark PA, Jenab M et al (2013) Prediagnostic body fat and risk of death from amyotrophic lateral sclerosis: The EPIC cohort. Neurology 80:829–838

3. O’Reilly ÉJ, Wang H, Weisskopf MG et al (2013) Premorbid body mass index and risk of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 14:205–211. https://www.ncbi.nlm.nih.gov/pubmed/23134505

4. Dorst J, Kühnlein P, Hendrich C, Kassubek J, Sperfeld AD (2011) Ludolph AC (2011) Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis. J Neurol 258:613–617

5. Dupuis L, Corcia P, Fergani A et al (2008) Dyslipidemia is a protective factor in amyotrophic lateral sclerosis symbol. Neurology 70(13):1004–1009

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Letter to the editor: Defining the cardiovascular phenotype of adults with Alstrom Syndrome;International Journal of Cardiology;2024-11

2. DALSO: domain ALS ontology;2024-06-03

3. Non-motor symptoms in patients with amyotrophic lateral sclerosis: current state and future directions;Journal of Neurology;2024-05-28

4. Update on recent advances in amyotrophic lateral sclerosis;Journal of Neurology;2024-05-27

5. Impact of demographic factors, comorbidities, and co‐medication on progression and survival in a large Chinese ALS cohort;Neurology and Clinical Neuroscience;2024-03-25